Barclays Downgrades Doximity to Equal-Weight, Lowers Price Target to $20
Doximity, Inc. Class A
Doximity, Inc. Class A DOCS | 0.00 |
Barclays analyst Glen Santangelo downgrades Doximity (NYSE:
DOCS) from Overweight to Equal-Weight and lowers the price target from $38 to $20.
